EP0792170A4 - Radionuklid-chelatverbindungen zur radiomarkierung von liganden, antiliganden oder verschiedenen proteinen - Google Patents

Radionuklid-chelatverbindungen zur radiomarkierung von liganden, antiliganden oder verschiedenen proteinen

Info

Publication number
EP0792170A4
EP0792170A4 EP94924458A EP94924458A EP0792170A4 EP 0792170 A4 EP0792170 A4 EP 0792170A4 EP 94924458 A EP94924458 A EP 94924458A EP 94924458 A EP94924458 A EP 94924458A EP 0792170 A4 EP0792170 A4 EP 0792170A4
Authority
EP
European Patent Office
Prior art keywords
ligands
radiotarking
proteins
metal chelates
radionuclides used
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP94924458A
Other languages
English (en)
French (fr)
Other versions
EP0792170A1 (de
Inventor
Linda M Gustavson
Sudhakar Kasina
Alan R Fritzberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Poniard Pharmaceuticals Inc
Original Assignee
Poniard Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Poniard Pharmaceuticals Inc filed Critical Poniard Pharmaceuticals Inc
Publication of EP0792170A1 publication Critical patent/EP0792170A1/de
Publication of EP0792170A4 publication Critical patent/EP0792170A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0497Organic compounds conjugates with a carrier being an organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A61K51/1054Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from lung
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005Compounds without a metal-carbon linkage
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP94924458A 1993-07-12 1994-07-12 Radionuklid-chelatverbindungen zur radiomarkierung von liganden, antiliganden oder verschiedenen proteinen Withdrawn EP0792170A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9042193A 1993-07-12 1993-07-12
US90421 1993-07-12
PCT/US1994/007733 WO1995002418A1 (en) 1993-07-12 1994-07-12 Radionuclide metal chelates for the radiolabeling of ligands, anti-ligands or other proteins

Publications (2)

Publication Number Publication Date
EP0792170A1 EP0792170A1 (de) 1997-09-03
EP0792170A4 true EP0792170A4 (de) 2000-03-15

Family

ID=22222702

Family Applications (1)

Application Number Title Priority Date Filing Date
EP94924458A Withdrawn EP0792170A4 (de) 1993-07-12 1994-07-12 Radionuklid-chelatverbindungen zur radiomarkierung von liganden, antiliganden oder verschiedenen proteinen

Country Status (3)

Country Link
EP (1) EP0792170A4 (de)
CA (1) CA2165052A1 (de)
WO (1) WO1995002418A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5556982A (en) * 1985-01-14 1996-09-17 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
WO1995005398A1 (en) * 1993-08-17 1995-02-23 Neorx Corporation S3n chelating compounds for the radiolabeling of ligands, anti-ligands or other proteins
US20090286875A1 (en) * 2005-11-17 2009-11-19 Pfizer, Inc. Isocystene derivatives for the treatment of pain

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0300431A2 (de) * 1987-07-22 1989-01-25 Neorx Corporation Methode zur Bindung von radionukliden Anschwefel enthaltende Chelate
WO1990015808A1 (en) * 1989-06-16 1990-12-27 Neorx Corporation Radionuclide metal chelates for the radiolabeling of proteins
WO1991009876A1 (en) * 1989-12-29 1991-07-11 Neorx Corporation Radiolabeled proteins for diagnostic or therapeutic use
WO1995002423A1 (en) * 1993-07-12 1995-01-26 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164176A (en) * 1989-06-16 1992-11-17 Neorx Corporation Radionuclide metal chelates for the radiolabeling of proteins

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0300431A2 (de) * 1987-07-22 1989-01-25 Neorx Corporation Methode zur Bindung von radionukliden Anschwefel enthaltende Chelate
WO1990015808A1 (en) * 1989-06-16 1990-12-27 Neorx Corporation Radionuclide metal chelates for the radiolabeling of proteins
WO1991009876A1 (en) * 1989-12-29 1991-07-11 Neorx Corporation Radiolabeled proteins for diagnostic or therapeutic use
WO1995002423A1 (en) * 1993-07-12 1995-01-26 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9502418A1 *

Also Published As

Publication number Publication date
CA2165052A1 (en) 1995-01-26
EP0792170A1 (de) 1997-09-03
WO1995002418A1 (en) 1995-01-26

Similar Documents

Publication Publication Date Title
FI960849A0 (fi) Metallikomplekseja sisältäviä farmaseuttisia koostumuksia
DZ1912A1 (fr) Hétéroaryl-oxazolidinones contenant de l'azote à 6members.
DE19781673T1 (de) Rückgewinnung von Wertmetallgehalten
NO972451D0 (no) 2-heterocyklyloksy og tiometyl-1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og fremgangsmåte for anvendelse derav
DE69731674D1 (de) Silencieux d'aspiration pour compresseur
BR9301417A (pt) Liga de niquel-molibdenio austentica e sua aplicacao
FI970300A0 (fi) Metallikelaattimerkityt peptidit
EP0705105A4 (de) Metallkomplexe als abstandshalter in biologisch aktiven peptiden
FR2692481B1 (fr) Composition cosmétique réductrice pour la déformation permanente des cheveux à base d'un mercaptoalkylamino-amide et procédé de déformation permanente des cheveux.
DE69615176D1 (de) Giessen von stahlbändern
DE69400995D1 (de) Alpha-Hydroxysäuren enthaltendes kosmetisches Shampoos
DE69600871D1 (de) Filtrierende kosmetische oder dermatologische Zusammensetzung enthaltend einen Eisen-Chelat-Bildner
EP0792170A4 (de) Radionuklid-chelatverbindungen zur radiomarkierung von liganden, antiliganden oder verschiedenen proteinen
DE69522582D1 (de) NEUE VERWENDUNGEN VON INDOLO-[2,3b]-CHINOXALINEN
TR199501328A2 (tr) Alzheimer peptidi.
FR2642966B1 (fr) Composition pour application capillaire
FR2718028B1 (fr) Nouvelles compositions cosmétiques ou dermopharmaceutiques contenant des hydrolysats peptidiques modifiés.
FR2600306B1 (fr) Perfectionnement aux dispositifs applicateurs d'etiquettes pour pieces de saucisson ou de preparations similaires
ITRM940124V0 (it) "brandina o cuccia pieghegole e/o smontabile"
MA23737A1 (fr) Trousse pour cycle de traitement de l'osteoporose
FR2644858B1 (fr) Joint d'etancheite pour roulement
ITMI950645V0 (it) Tegola di raccordo colmo-passaggio d'angolo
EP0707493A4 (de) Kolokalisation von zielmolekuel und seinem inhibitor
KR960009711U (ko) 남자용 팬츠
FR2727701B3 (fr) Composition de revetement pour pistes, d'hippisme notamment

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19960212

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20000131

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7A 61K 51/04 A, 7A 61K 51/10 B, 7C 07K 5/06 B, 7C 07F 13/00 B

17Q First examination report despatched

Effective date: 20001019

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NEORX CORPORATION

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20040630